The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Relay Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news flow emerging out of the sector.FDA approved a few drugs, including Endo International PLC's (NASDAQ: ENDP) cellulite treatment, while Merck & Co., Inc. (NYSE: MRK)-Eisai Co., Ltd's (OTC: ESALY) combo therapy was rejected by
finance.yahoo.com